The first level of prevention - programs for vaccination of girls against HPV and regular screening of women for HPV infection and why routine and preventive vaccination is necessary in the Republic of Kazakhstan

Amireev , S., Jumatova , U.K., Tiesova-Berdalina , R.A., Baimuratova, M.A., Ryskulova , A.R., Tugulbaeva, A.S., Abdusalamova, Z.S., Амиреев, С., Джуматова , У.К., Тьесова-Бердалина , Р.А., Баймуратова , М.А., Рыскулова , А.Р., Тугулбаева, А.С., Абдусаламова, З.С.

Жамият ва инновациялар / Общество и инновации / Society and innovations · 2021-yil

Annotatsiya

Worldwide, human papillomavirus (HPV) infection is one of the most common sexually transmitted infections. HPV can cause the development of malignant neoplasms, as cancer of the vulva, vagina, anal penis, oropharynx and cervix. Three HPV vaccines are currently available: bivalent (HPV 16,18), tetravalent (HPV 6,11,16,18), and non-valent (6,11,16,18,31,33,45,52,58). This article provides a comparative assessment of the effectiveness of the vaccines "Gardasil" and "Cervarix" in the fourth phase - at the post-marketing or post-registration phase, after the vaccine preparations have entered the market of our republic, assumptions are made about the advantages of widespread vaccination against HPV. HPV vaccines represent a promising primary approach to the prevention of HPV-associated malignancies. According to the literature, elimination of HPV infection is predicted at 80% global vaccination rates and benefits in reducing malignancy at 20% global coverage.

Maqola ma’lumotlari
MualliflarAmireev , S., Jumatova , U.K., Tiesova-Berdalina , R.A., Baimuratova, M.A., Ryskulova , A.R., Tugulbaeva, A.S., Abdusalamova, Z.S., Амиреев, С., Джуматова , У.К., Тьесова-Бердалина , Р.А., Баймуратова , М.А., Рыскулова , А.Р., Тугулбаева, А.С., Абдусаламова, З.С.
JurnalЖамият ва инновациялар / Общество и инновации / Society and innovations
Nashr sanasi2021-04-05
Jild2
Son2
Betlar239-247
TilRus
DOI10.47689/2181-1415-vol2-iss2-pp239-247

Kalit so‘zlar

вакцинопрофилактика, рак шейки матки, вирус папилломы человека, оценка эффективности, vaccine prevention, human papillomavirus, assessment of effectiveness

Ilmiy soha

Жамият ва инновациялар / Общество и инновации / Society and innovations jurnalidan boshqa maqolalar

Жамият ва инновациялар / Общество и инновации / Society and innovations — barcha maqolalar